icometrix is a Leuven, Belgium-based global expert in brain imaging artificial intelligence solutions that provides the icobrain software. Icobrain extracts clinically meaningful information from brain MRI and CT scans of patients with neurological disorders such as Multiple Sclerosis, Alzheimer’s disease and dementia, and traumatic brain injury. Both CE-marked and FDA-cleared, the icobrain AI solutions are already used in more than 100 hospitals and imaging center networks worldwide and in clinical studies by 4 out of the Top 5 pharmaceutical companies. Led by CEO Wim Van Hecke, the company intends to use the $18M in funding to continue to develop its technology. The $18M round was led by Forestay Capital with participation from Optum Ventures and existing investor Capricorn Venture Partners.

Total raised

$18M

Funding rounds

1

Latest round

Equity

Latest activity

May 2019